Myristic Acid Solid Lipid Nanoparticles Enhance the Oral Bioavailability and Therapeutic Efficacy of Rifaximin against MRSA Pneumonia
This study indicates that the myristic acid solid lipid nanoparticles might be an effective way to enhance the oral absorption and therapy effects of RFX and other insoluble drugs.
Authors
- Aoxue Zhang (ORCID: https://orcid.org/0009-0006-0126-2813)
- Yumin Zhang (ORCID: https://orcid.org/0000-0002-9806-4277)
- Shuyu Xie
- Dongmei Chen
Institutions
- Huazhong Agricultural University (CN)
- Agricultural Genomics Institute at Shenzhen (CN)
- Chinese Academy of Agricultural Sciences (CN)
Publication Details
- Journal
- Current Drug Delivery
- Published
- 2024-08-15
- DOI
- https://doi.org/10.2174/0115672018276382231207103955
- Citations
- 1
- Primary Topic
- Pneumocystis jirovecii pneumonia detection and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39